What Happened?
Shares of water technology company Xylem (NYSE: XYL) jumped 4.4% in the morning session after the company reported second-quarter results that beat profit estimates and included a raised full-year earnings forecast, despite a miss on other key metrics. The company posted an adjusted profit of $1.46 per share, which was 9.2% above the analyst consensus of $1.34. However, the quarter presented a mixed picture for investors. While revenue of $2.34 billion was in line with expectations, the company's adjusted EBITDA of $437 million missed estimates by 15.5%.
Furthermore, Xylem lowered its full-year revenue guidance to $9.2 billion at the midpoint. Despite these headwinds, investors appeared to focus on the positives, including an increase in operating margin to 16.7%, up from 13.3% in the same quarter last year. Reflecting this improved profitability, Xylem raised its full-year adjusted EPS guidance to a midpoint of $5.63.
The shares were trading at $125.79, up 4.7% from the previous close.
Is now the time to buy Xylem? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Xylem’s shares are not very volatile and have only had 4 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business.
The biggest move we wrote about over the last year was 12 months ago when the stock gained 9.5% on the news that the company reported strong second-quarter results, beating analyst expectations and raising its full-year guidance. The water technology firm posted quarterly revenue of $2.3 billion, surpassing analyst estimates. On an adjusted basis, Xylem earned $1.26 per share, also beating Wall Street forecasts. The company noted that robust organic revenue growth across all segments drove the positive results. Following the strong performance, Xylem increased its full-year 2025 sales forecast to a range of $8.9 billion to $9.0 billion. It also lifted its adjusted earnings per share projection to between $4.70 and $4.85, signaling confidence for the remainder of the year.
Xylem is down 8.3% since the beginning of the year, and at $125.79 per share, it is trading 17.8% below its 52-week high of $152.95 from October 2025. Despite the year-to-date decline, investors who bought $1,000 worth of Xylem’s shares 5 years ago would now be looking at an investment worth $1,023.
ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.
AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.
